FloraLo

Associate

Hong Kong + 852.3189.7223

Flora Lo's practice focuses on M&A, capital markets, and general corporate matters. She advises clients in Hong Kong and China on M&A, initial public offerings on the Main Board and the Growth Enterprise Market (GEM) Board of the Hong Kong Stock Exchange, joint ventures, and regulatory compliance.

Prior to joining Jones Day in 2018, Flora practiced at an international law firm and at one of the first private Chinese law firms. During this time she represented: IMS Group Holdings, an LED lighting products and services provider, in its initial public offering on the GEM of the Hong Kong Stock Exchange; the joint sponsors of a listing applicant engaged in the financial services industry in its proposed initial public offering on the GEM of the Hong Kong Stock Exchange; a private company in its approximately HK$76.5 million acquisition of 51 percent shares in a company that provides ground handling services at the Hong Kong International Airport; a private company in its proposed acquisition of shares in a Hong Kong company that provides cargo handling at the Hong Kong International Airport; and China Renewable Energy Investment Limited in its bonus issue of warrants.

Experience

  • GenScript Biotech Corporation completes US$423.8 million IPO and spin-off of its subsidiary Legend Biotech Corporation; and US$24 million purchase of Ordinary Shares of Legend BiotechJones Day acted as the U.S. and Hong Kong legal advisors of GenScript Biotech Corporation (“GenScript Biotech”) in relation to its (a) approximately US$423.8 million initial public offering of 18,425,000 American Depositary Shares and spin-off listing of its subsidiary Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”) on the Nasdaq Global Select Market and (b) approximately US$24 million purchase of Ordinary Shares of Legend Biotech in a concurrent private placement of Legend Biotech.
  • Sino Power Resources completes subscription of new shares in FDG Electric Vehicles LimitedJones Day assisted Sino Power Resources Inc., a subsidiary of China Orient Asset Management (International) Holding Limited, in connection with its subscription of new shares in FDG Electric Vehicles Limited, a vertically-integrated electric vehicle manufacturer.
  • GenScript Biotech Corporation completes placement of sharesJones Day advised GenScript Biotech Corporation (the “GenScript”, together with its subsidiaries, the “GenScript Group”), a company listed on The Stock Exchange of Hong Kong Limited, on its US$255 million top-up placing of shares and Ms. Ye Wang, a director, president, and controlling shareholder of GenScript on her US$51 million placing of shares.
  • CCB International Asset Management invests in Xinming China Holdings LimitedJones Day represented CCB International Asset Management Limited in connection with its investment in Xinming China Holdings Limited, an investment holding company principally engaged in property development, via the purchase of convertible bonds.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.